政府及保監局歡迎世銀巨災債券在港上市
政府和保險業監管局歡迎世界銀行在香港以巨災債券形式發行總額為3.5億美元的保險相連證券,為智利未來三年與地震風險有關的損失提供保障。
財政司司長陳茂波表示,今次是香港第四次發行保險相連證券,也是此類證券首次上市,足證香港的國際金融中心地位和香港保險業的蓬勃發展。
財經事務及庫務局局長許正宇,政府早在2021年推出保險相連證券的專屬規管制度和資助先導計劃,期望藉此吸引更多發行機構和專業人才來港,建立蓬勃的市場生態圈。今日的發行及上市正好展現了香港的獨特橋樑角色。
保監局主席姚建華指,世界銀行作為舉足輕重的國際組織,決定以香港為合作夥伴 , 是香港致力成為 具活力的保險相連證券樞紐的歷程中,一項重要里程碑 。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.